arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Talphera, Inc.

TLPH Health Care Biotechnology: Pharmaceutical Preparations
$1.07
0.0% Today
as of Oct 23, 13:51 ET
Last 30 days -13.71% Sep 14 → Oct 23
$1.03 $1.09 $1.14 $1.20 $1.26 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.08
High
$1.10
Low
$1.05
Volume
$35,957
Avg Vol
$254,662
Mkt Cap
$58M
P/E (TTM)
—
Beta
—
52w High
$1.57
52w Low
$0.69
Div Yield
—
Shares Out
$52M

Recent Press Releases & News last 60 days · 2 items

Sep 21 · 16:00 Zacks
Talphera (TLPH) Upgraded to Buy: Here's What You Should Know
Sep 3 · 12:30 PR PR Newswire
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

TLPH earnings at a glance

The options market is pricing a move of about ±259.3% after the report, a range of roughly -$1.70 to $3.84 from today's $1.07. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.3% on average; after the most recent report on May 13, 2026 it moved +4.7%. That means options currently expect more movement than TLPH has typically delivered. Implied volatility is currently 22%. The share price of $1.07 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.69
$1.57
43% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+1.4%
50% positive
Latest IV / EM
2195%
EM ±259.3% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.40$-0.31$-0.22$-0.13$-0.04 Actual $-0.40Actual $-0.08Actual $-0.16Actual $-0.10Actual $-0.10Actual $-0.11Actual $-0.04 JunSepMarMar/2025Jun/2025Sep/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-4M$-3M$-2M$-1M$28,350 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.04 — — +60.0% +4.7% earnings
Wed Nov 12, 2025Sep/2025 $-0.11 — — — — earnings
Thu Aug 14, 2025Jun/2025 $-0.10 — — — — earnings
Wed May 14, 2025Mar/2025 $-0.10 — — — -1.9% earnings
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.08 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.40 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$0$0—$1,000$0$27,000—$0
Cost of revenue————————
Gross profit————————
Operating income$-4M$-4M—$-3M$-4M$-3M—$-4M
Net income$-4M$-3M—$-4M$-3M$-3M—$-3M
EPS (diluted)—————$-0.10——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$742,000$4M$6M$3M$7M$5M$9M$11M
Inventory————————
Total current assets$18M$21M$21M$22M$8M$6M$9M$12M
Total assets$27M$30M$30M$31M$17M$15M$18M$21M
Long-term debt————————
Total liabilities$12M$12M$13M$12M$10M$9M$10M$11M
Total equity$14M$18M$17M$19M$7M$6M$8M$10M

Implied volatility — last 90 days

803%1958%3113%4268%5423% Jun 19 — IV 1266% · EM ±279.8%Jun 22 — IV 1414% · EM ±295.3%Jun 23 — IV 1396% · EM ±285.7%Jun 24 — IV 1390% · EM ±278.3%Jun 25 — IV 1455% · EM ±285.0%Jun 26 — IV 1623% · EM ±310.7%Jun 29 — IV 1639% · EM ±290.5%Jun 30 — IV 1663% · EM ±286.4%Jul 01 — IV 1739% · EM ±290.5%Jul 02 — IV 1589% · EM ±257.0%Jul 03 — IV 1645% · EM ±257.0%Jul 06 — IV 964% · EM ±133.5%Jul 07 — IV 1686% · EM ±222.7%Jul 08 — IV 1756% · EM ±220.0%Jul 09 — IV 1587% · EM ±187.5%Jul 10 — IV 1387% · EM ±153.2%Jul 13 — IV 1897% · EM ±158.5%Jul 14 — IV 2214% · EM ±160.1%Jul 15 — IV 2646% · EM ±156.2%Jul 16 — IV 3902% · EM ±163.0%Jul 20 — IV 804% · EM ±189.9%Jul 21 — IV 837% · EM ±194.7%Jul 22 — IV 878% · EM ±200.8%Jul 23 — IV 860% · EM ±193.4%Jul 24 — IV 838% · EM ±185.2%Jul 27 — IV 1007% · EM ±210.3%Jul 28 — IV 959% · EM ±196.2%Jul 29 — IV 953% · EM ±190.8%Jul 30 — IV 940% · EM ±184.2%Jul 31 — IV 1021% · EM ±195.3%Aug 03 — IV 1040% · EM ±184.2%Aug 04 — IV 1003% · EM ±172.8%Aug 05 — IV 1008% · EM ±168.4%Aug 06 — IV 973% · EM ±157.3%Aug 07 — IV 1053% · EM ±164.5%Aug 10 — IV 1203% · EM ±166.7%Aug 11 — IV 1133% · EM ±149.7%Aug 12 — IV 1330% · EM ±166.7%Aug 13 — IV 2099% · EM ±247.9%Aug 14 — IV 1950% · EM ±215.4%Aug 17 — IV 2544% · EM ±212.5%Aug 18 — IV 3256% · EM ±235.5%Aug 19 — IV 3913% · EM ±231.1%Aug 20 — IV 5332% · EM ±222.7%Aug 24 — IV 1147% · EM ±239.5%Aug 25 — IV 1102% · EM ±225.4%Aug 26 — IV 971% · EM ±194.4%Aug 27 — IV 1141% · EM ±223.6%Aug 28 — IV 1197% · EM ±229.2%Aug 31 — IV 1233% · EM ±218.5%Sep 01 — IV 1304% · EM ±224.6%Sep 02 — IV 1322% · EM ±220.8%Sep 03 — IV 1365% · EM ±220.8%Sep 04 — IV 1413% · EM ±220.8%Sep 07 — IV 1594% · EM ±220.8%Sep 08 — IV 1750% · EM ±231.1%Sep 09 — IV 1734% · EM ±217.2%Sep 10 — IV 1707% · EM ±201.6%Sep 11 — IV 1934% · EM ±213.7%Sep 14 — IV 2462% · EM ±205.6%Sep 15 — IV 3020% · EM ±218.5%Sep 16 — IV 3770% · EM ±222.7%Sep 17 — IV 5423% · EM ±226.5%Sep 21 — IV 1135% · EM ±237.1%Sep 22 — IV 1149% · EM ±235.0%Sep 23 — IV 1184% · EM ±237.1%Sep 24 — IV 1200% · EM ±235.0%Sep 25 — IV 1196% · EM ±228.8%Sep 28 — IV 1304% · EM ±231.1%Sep 29 — IV 1315% · EM ±226.5%Sep 30 — IV 1368% · EM ±228.4%Oct 01 — IV 1518% · EM ±245.5%Oct 02 — IV 1557% · EM ±243.4%Oct 06 — IV 1876% · EM ±247.7%Oct 07 — IV 2204% · EM ±276.2%Oct 08 — IV 2195% · EM ±259.3%

Sector peers

CLNN
Clene Inc.
$57M $3.84+2.1%
HYPD
Hyperion DeFi, Inc.
$57M $2.83-8.6%
BOLD
Boundless Bio, Inc.
$60M $2.38-2.7%
PDSB
PDS Biotechnology Corporation
$51M $1.10-11.4%
DOMH
Dominari Holdings Inc.
$51M $1.75-9.3%
ELTX
Elicio Therapeutics, Inc.
$50M $1.94+15.9%

TLPH earnings FAQ

What is TLPH's expected move for earnings?

Options currently price a move of about ±259.3%, or $2.77 per share either way from $1.07.

How does TLPH stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.3%, up 1 times and down 1 times.

What is TLPH's implied volatility?

TLPH's at-the-money implied volatility is about 22% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in